OM336 in Seropositive Autoimmune Diseases

Clinical trial NCT07229144 · RECRUITING

Trial details

NCT number: NCT07229144
Sponsor: Lakefront Biotherapeutics West LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Sjogrens Disease Idiopathic Inflammatory Myopathy (IIM)

Start date: 2025-10-01
Primary completion: 2027-06-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.